Edition:
United States

Madrigal Pharmaceuticals Inc (MDGL.OQ)

MDGL.OQ on NASDAQ Stock Exchange Capital Market

110.24USD
14 Dec 2018
Change (% chg)

$1.92 (+1.77%)
Prev Close
$108.32
Open
$106.23
Day's High
$113.12
Day's Low
$106.23
Volume
91,220
Avg. Vol
92,610
52-wk High
$325.58
52-wk Low
$77.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.556
Jun '18 0.00 -0.449
Mar '18 0.00 -0.450
FY 2017 Dec '17 0.00 -0.670
Sep '17 0.00 -0.676
Jun '17 0.00 -0.693
Mar '17 0.00 -0.502
FY 2016 Dec '16 0.00 -0.591
Sep '16 0.00 -1.588
Jun '16 0.00 -16.332
Mar '16 0.00 -9.724
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 5 0.00 0.00 0.00 --
Year Ending Dec-18 8 0.00 0.00 0.00 0.00
Year Ending Dec-19 8 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 9 -0.76 -0.61 -1.07 -0.88
Quarter Ending Mar-19 8 -1.24 -0.75 -3.12 -1.80
Year Ending Dec-18 9 -2.26 -2.07 -2.87 -3.13
Year Ending Dec-19 10 -5.43 -3.19 -13.97 -5.32
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta 0.82 1.08 0.91
Price to Sales (TTM) -- 49.58 6.22
Price to Book (MRQ) 9.52 10.17 5.20
Price to Tangible Book (MRQ) 9.52 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 65.89 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 95.75 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago 87.58 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -66.12 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 10.56 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -1.67 -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -176,177.20 -109.98 13.16
Operating Margin (TTM) -- -185.00 6.07
Operating Margin - 5 Yr. Avg. -177,488.09 -126.42 8.47
Pre-Tax Margin (TTM) -- -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -185,289.59 -132.58 8.71
Net Profit Margin (TTM) -- -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -185,289.59 -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,649,006 873,053,182
Net Income/Employee (TTM) -4,518,001 653,334 103,483,965
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -63.97 6.47 11.45
Return on Assets - 5 Yr. Avg. -79.87 5.54 12.50
Return on Investment (TTM) -70.04 9.01 14.96
Return on Investment - 5 Yr. Avg. -139.54 6.87 16.23
Return on Equity (TTM) -70.04 10.15 16.52
Return on Equity - 5 Yr. Avg. -164.11 8.41 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -343.35 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Madrigal Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 164.84 155.71 99 98
13 Week 188.98 174.90 99 94
26 Week 212.03 188.31 99 98
52 Week 188.09 144.18 99 68
YTD 214.97 176.60 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 93.36%
# of Holders: 218
Total Shares Held: 14,370,646
3 Mo. Net Change: 447,201
# New Positions: 38
# Closed Positions: 34
# Increased Positions: 121
# Reduced Positions: 90
# Net Buyers: 31
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.